Recurring trade-off costs
- Biosynthetic cost: glycolytic reprogramming supports biosynthesis but yields far less ATP per glucose, forcing high glucose consumption.
- Oxidative cost: sustained ROS production from mitochondrial and inflammatory programs exceeds the finite antioxidant reserve and damages macromolecules.
- Structural cost: matrix metalloproteinases clear damaged tissue acutely but degrade matrix architecture when released continuously.
- Opportunity cost: commitment to a survival and secretory program displaces the cell's differentiated function, so tissue function falls even while cells survive.
A cost made concrete
A secretory cell that sustains high UPR output survives by expanding its ER and increasing chaperone synthesis, but that expansion consumes a large share of the cell's ATP and amino acid supply. If the same cell also faces nutrient limitation, the biosynthetic cost of the UPR competes directly with the biosynthetic cost of the glycolytic survival program, and neither program can be fully funded. The cell survives the secretory stress but becomes vulnerable to a second stress it would otherwise have tolerated.